LWLG

Business Context and Reporting Period

Company: Lightwave Logic, Inc. (formerly Third-Order Nanotechnologies, Inc.)
Filing Type: Form 10-Q (Unaudited)
Period Ended: March 31, 2009
Status: Development Stage Company
Business Overview: The Company develops high-activity, high-stability electro-optic polymers intended for use in fiber-optic, wireless, and satellite communication networks. The Company has not yet commenced revenue-generating operations and relies on equity financing and the exercise of warrants to fund research and development (R&D).

Key Financial Metrics

Cash Flow Summary (Q1 2009):
- Net cash used in operating activities: $(259,452)
- Net cash used in investing activities: $(1,185)
- Net cash provided by financing activities: $367,872 (primarily from warrant exercises and subscription receivables).

Material Changes vs. Prior Period

• Net Loss Reduction: Net loss decreased by $252,422 (25%) compared to Q1 2008, driven primarily by a $209,118 reduction in operating expenses.
• Expense Breakdown:
  • General & Administrative (G&A): Decreased by $282,946 to $307,267. This was due to the non-renewal of a management contract (saving $127,004), reduced legal fees ($95,568 decrease), and elimination of market research fees ($75,319 decrease).
  • Research & Development (R&D): Increased by $73,828 to $449,717, attributed to higher employee compensation for R&D staff.
• Other Income/Expense: Q1 2008 included a $47,500 litigation settlement expense which was not present in Q1 2009.
• Liquidity: Cash balances increased from $88,225 at year-end 2008 to $195,460 at March 31, 2009, supported by financing activities.

Outlook, Risks, and Management Commentary

• Going Concern: The filing includes a "Going Concern" warning. The Company has incurred significant losses and negative cash flows. Management estimates funds are sufficient only through May 2009. Additional financing is required to continue operations.
• Development Status: The Company is developing a prototype photonic chip. While engineering setbacks were overcome, production was temporarily halted. Management aims to demonstrate a prototype by the mid-second quarter of 2009.
• Capital Requirements: The Company expects to incur approximately $700,000 to $1,000,000 in expenditures for the remainder of 2009. Future funding may come from equity offerings, warrant exercises, or debt, though no assurances are provided.
• Legal Contingencies:
  • SEC Investigation: The SEC is investigating a 2005 private offering regarding potential violations of registration provisions. The Company has complied with subpoenas, but no action has been taken as of the filing date.
  • Litigation: A lawsuit filed by Ronald R. Genova was settled in May 2008 for $47,500.
• Intellectual Property: The Company received first office actions on two patent applications in early 2009 regarding "Heterocyclic Chromophore Architectures" and "Tricyclic Spacers."

Investor Verification Checklist

• Cash Runway: Verify the Company's ability to secure financing before May 2009, as current cash reserves are insufficient for long-term operations.
• Prototype Timeline: Monitor progress on the electro-optic polymer prototype, as commercialization and future revenue depend entirely on successful demonstration.
• SEC Investigation Status: Track any updates regarding the SEC investigation into the 2005 private offering, which could result in enforcement actions.
• Dilution Risk: Review the significant number of outstanding warrants and options (7.1 million outstanding as of March 31, 2009) and the Company's reliance on equity issuance for funding.
• Related Party Transactions: Note the significant issuance of stock and warrants to related parties for services, which impacts expense recognition and equity structure.